Lab results
LOT # Pending Pending Lab Results PENDING
Every batch is independently tested by HPLC and LC-MS. Certificates of analysis are available above and included in every shipment.
CJC-1295 (No DAC)/Ipamorelin is a research peptide blend that combines a synthetic growth hormone-releasing hormone (GHRH) analog with a selective growth hormone secretagogue. This investigational combination has become widely studied for its potential role in growth hormone signaling, endocrine function, and metabolic pathway research.
Researchers have explored CJC-1295 (No DAC)/Ipamorelin in laboratory models involving recovery mechanisms, sleep-related pathways, body composition, and IGF-1 signaling. Its complementary mechanisms of action have made it a popular choice in studies focused on peptide synergy and pulsatile growth hormone release.
Research Applications:
- Growth hormone and IGF-1 research
- Endocrine and metabolic studies
- Sleep and recovery investigations
- Body composition research
- Cellular signaling pathway analysis
Compound information
- Product Specifications: CJC-1295 (No DAC) + Ipamorelin (10 mg total) lyophilized powder blend in a sealed sterile vial.
- Application: Research reagent for in-vitro and preclinical pathway investigation. Not for human or veterinary use.
- Appearance: White Lyophilized Powder
- Type: Research Peptide Blend
- State: Lyophilized Powder
- Amino Acid Information: 30 amino acids (CJC-1295) + 5 amino acids (Ipamorelin)
- Fatty Acid Chain: None
- Chemical Formula: Not Applicable
- CAS Number: Not Assigned
- Molecular Weight: Not Applicable
- Purity: 99.87%
- Storage: −20°C long-term, protect from light and moisture. 2–8°C after reconstitution; use within 30 days.
For Research Use Only. CJC-1295 (No DAC)/Ipamorelin is an investigational peptide blend and is not approved by the FDA for human or veterinary use. This product is intended strictly for laboratory and scientific research purposes.
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
You assume all risk associated with the handling, storage, and use of CJC + IPAMORELIN. LAZY LABS disclaims all liability for misuse. CJC + IPAMORELIN has not been approved by the FDA for human or veterinary use except for specific approved indications, and is intended strictly for laboratory and scientific research purposes.
